Synthesis of new biodegradable nanocarriers for SN38 delivery and synergistic phototherapy

Document Type: Research Paper

Authors

1 Department of Chemistry, School of Chemistry, Damghan University, Damghan, Iran

2 Faculty of Chemical, Gas and Petroleum Engineering, Semnan University, Semnan, Iran

3 Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Objective (s): SN38 is the prominent and effective anticancer drug for treating various types of human cancers such as colorectal, ovarian and lung cancers. SN38 is highly toxic, and due to its poor solubility in aqueous media, and low stability and hydrolysis at physiological pH, it has not been used as an anti-cancer drug. To overcome these problems, SN38 was conjugated with new nanocarriers in order to efficiently deliver it into cancer cells.
Materials and Methods: we report the synthesis of nanocarriers based on covalent attachment of graphene oxide with β-cyclodextrin and coordinated with superparamagnetic iron oxide nanoparticles for SN38 loading and delivery. Using SPION-functionalized graphene oxide provides magnetic properties and local hyperthermia due to laser irradiation at 808 nm. Structures were characterized by using FT-IR spectroscopy and the size and morphology of the nanoparticles were determined using Malvern Zetasizer and FE-SEM, respectively.
Results: The prepared nanoplatform was not significantly toxic to HT-29 cells. However, the developed graphene oxide-based nanocarrier containing SPION and SN38 was used to improve the chemotherapy through photothermal and photodynamic therapy. The optimal laser wavelength (808 nm) for PTT is consistent with that of IR-808 for PDT and the β-CD-GO-EDTA-Fe3O4-SN38 indicated synergistic effects of both drugs and SPION.
Conclusion: Biocompatible nanocarrier based on functionalized graphene oxide (β-CD-GO-EDTA-Fe3O4-SN38) demonstrated strong synergistic cytotoxic activity. The new formulation has a great potential as chemo-photothermal-photodynamic therapy agents in synergistic phototherapy.

Keywords


1. Atyabi F, Farkhondehfai A, Esmaeili F, Dinarvand R. Preparation of pegylated nano-liposomal formulation containing SN-38: in vitro characterization and in vivo biodistribution in mice. Acta Pharm. 2009; 59(2): 133-144.
2. Rong P, Wu J, Liu Z, Ma X, Yu L, Zhou K, Zeng W, Wang W. Fluorescence dye loaded nano-graphene for multimodal imaging guided photothermal therapy. RSC Adv. 2016; 6(3): 1894-1901.
3. Lee P-C, Chiou Y-C, Wong J-M, Peng C-L, Shieh M-J. Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody. Biomaterials. 2013; 34(34): 8756-8765.
4. Bala V, Rao S, Boyd BJ, Prestidge CA. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J Control Release. 2013; 172(1): 48-61.
5. Sepehri N, Rouhani H, Ghanbarpour AR, Gharghabi M, Tavassolian F, Amini M, Ostad SN, Ghahremani MH, Dinarvand R. Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatment. Biomed Res Int. 2014; 2014: 963507.
6. Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013; 9(12): 9243-9257.
7. Seabra AB, Paula AJ, de Lima R, Alves OL, Duran N. Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol.. 2014; 27(2): 159-168.
8. Wei Z, Wang D, Kim S, Kim S-Y, Hu Y, Yakes MK, Laracuente AR, Dai Z, Marder SR, Berger C, King WP, de Heer WA, Sheehan PE, Riedo E. Nanoscale tunable reduction of graphene oxide for graphene electronics. Science. 2010; 328(5984): 1373-1376.
9. Kiew SF, Kiew LV, Lee HB, Imae T, Chung LY. Assessing biocompatibility of graphene oxide-based nanocarriers: a review. J Control Release. 2016; 226: 217-228.
10. Vangara KK, Ali HI, Lu D, Liu JL, Kolluru S, Palakurthi S. SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer. AAPS PharmSciTech. 2014; 15(2): 472-482.
11. Alibolandi M, Mohammadi M, Taghdisi SM, Ramezani M, Abnous K. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017; 155: 218-229.
12. Hu J, Qian Y, Wang X, Liu T, Liu S. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging. Langmuir. 2011; 28(4): 2073-2082.
13. Liu Z, Robinson JT, Sun X, Dai H. PEGylated nano-graphene oxide for delivery of water insoluble cancer drugs. J Am Chem Soc. 2008; 130(33): 10876-10877.
14. Einafshar E, Asl AH, Nia AH, Mohammadi M, Malekzadeh A, Ramezani M. New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite. Carbohydr Polym. 2018; 194: 103-110.
15. Sapra P, Zhao H, Mehlig M, Malaby J, Kraft P, Longley C, Greenberger LM, Horak ID. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11–refractory model. Clin Cancer Res. 2. 2008; 14(6): 1888-1896.
16. Huang X, El-Sayed MA. Plasmonic photo-thermal therapy (PPTT). Alexanderia Journal of Medicine. 2011; 47: 1-9.
17. Shibu ES, Hamada M, Murase N, Biju V. Nanomaterials formulations for photothermal and photodynamic therapy of cancer. J Photochem Photobiol C: Photochem Rev. 2013; 1(5): 53-72.
18. Luo S, Yang Z, Tan X, Wang Y, Zeng Y, Wang Y, Li C, Li R, Shi C. Multifunctional photosensitizer grafted on polyethylene glycol and polyethylenimine dual-functionalized nanographene oxide for cancer-targeted near-infrared imaging and synergistic phototherapy. ACS Appl Mater Interfaces. 2016; 8(27): 17176-17186.
19. Hummers Jr WS, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958; 80(6): 1339.
20. El Ghandoor H, Zidan H, Khalil MM, Ismail M. Synthesis and some physical properties of magnetite (Fe3O4) nanoparticles. Int J Electrochem Sci. 2012; 7(6): 5734-5745.
21. Lu L, Zheng Y, Weng S, Zhu W, Chen J, Zhang X, Lee RJ, Yu B, Jia H, Qin L. Complete regression of xenograft tumors using biodegradable mPEG-PLA-SN38 block copolymer micelles. Colloids Surf B Biointerfaces. 2016; 142: 417-423.
22. Liu Y, Piao H, Gao Y, Xu C, Tian Y, Wang L, , Liu J, Tang B, Zou M, Cheng G. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity. Int J Nanomedicine. 2015; 10: 2295-2311.
23. Meng F, Cheng R, Deng C, Zhong Z. Intracellular drug release nanosystems. Mater Today. 2012; 15(10): 436-442.
24.Alibolandi M, Ramezani M, Abnous K, Sadeghi F, Atyabi F, Asouri M, Ahmadi AA, Hadizadeh Fet al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015; 209: 88-100.